Vanda Pharmaceuticals
VNDA
VNDA
146 hedge funds and large institutions have $202M invested in Vanda Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
15% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 54
77% less call options, than puts
Call options by funds: $748K | Put options by funds: $3.23M
Holders
146
Holding in Top 10
–
Calls
$748K
Puts
$3.23M
Top Buyers
| 1 | +$6.75M | |
| 2 | +$1.72M | |
| 3 | +$1.56M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.31M |
| 5 |
Universal-Beteiligungs- und Servicegesellschaft
Frankfurt Am Main,
Germany
|
+$875K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$1.74M | |
| 3 | -$1.32M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$902K |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$891K |